CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-24 | BioXcel Holdings, Inc. 10% owner | Other disposition | −160,000 | $60.76 | $9.7M | 0 |
| 2020-07-24 | BioXcel LLC 10% owner | Other disposition | −160,000 | $60.76 | $9.7M | 9,020,000 |
| 2020-07-24 | Mehta Vimal CEO, President and Secretary | Other disposition | −160,000 | $60.76 | $9.7M | 9,020,000 |
| 2020-07-24 | Mehta Vimal CEO, President and Secretary | Other acquisition | +80,000 | $60.76 | $4.9M | 80,000 |
| 2020-07-24 | Nandabalan Krishnan Director | Other disposition | −160,000 | $60.76 | $9.7M | 9,020,000 |
| 2020-07-24 | Nandabalan Krishnan Director | Other acquisition | +80,000 | $60.76 | $4.9M | 80,000 |
| 2020-06-22 | Benabou Reina See Remarks | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2020-06-15 | Kane William P Jr Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +110,000 | 110,000 | ||
| 2020-05-26 | Yocca Frank Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2020-05-26 | Steinhart Richard I Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +55,000 | 55,000 | ||
| 2020-05-26 | Mehta Vimal CEO, President and Secretary | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2020-05-26 | O'Neill Vincent Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2020-05-21 | Laumas Sandeep Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-05-21 | MUELLER PETER Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-05-21 | MUELLER PETER Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2020-05-21 | Votruba Michal Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2020-05-21 | Votruba Michal Director | Other disposition · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2020-02-24 | Mehta Vimal CEO, President and Secretary | Returned to the company | −300,000 | $30.08 | $9.0M | 9,180,000 |
| 2019-04-01 | Nandabalan Krishnan Director | Gift | −1,000 | 0 | ||
| 2019-04-01 | Nandabalan Krishnan Director | Gift | +1,000 | 1,000 |
Page 26 of 27 · 521 trades